Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | GGH | Q92820 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | MME | P08473 | 1/20 | 0.34 |
| ▸ | ECE1 | P42892 | 1/20 | 0.34 |
| ▸ | PGK1 | P00558 | 1/20 | 0.33 |
| ▸ | PGK2 | P07205 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8968009 | 1.00 | CA2 (0.39) | CA2CA4NPSR1GGHPTPN1 | |
| SCHEMBL8968828 | 0.87 | KMT2A (0.40) | ALDH1A1GAA | |
| SCHEMBL8968840 | 0.87 | KMT2A (0.40) | ALDH1A1GAA | |
| SCHEMBL8968802 | 0.84 | POLB (0.38) | NPSR1 | |
| SCHEMBL25435209 | 0.84 | POLB (0.38) | NPSR1 | |
| SCHEMBL9300028 | 0.81 | CYP3A4 (0.39) | ALDH1A1 | |
| SCHEMBL9299511 | 0.81 | CYP3A4 (0.39) | ALDH1A1 | |
| SCHEMBL9299497 | 0.81 | CYP3A4 (0.39) | ALDH1A1 | |
| SCHEMBL7224170 | 0.80 | MAPT (0.45) | CA2NPSR1MMEALDH1A1GAA | |
| SCHEMBL2021383 | 0.77 | ALDH1A1 (0.48) | CA2NPSR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5554773-A | N-trityl protected aspartic acid derivatives for the preparation of phosphonate NMDA antagonists | MERRELL PHARMACEUTICALS INC. (US) | 1996-09-10 | — | — | US | disclosed |
| US-5554773-A | N-trityl protected aspartic acid derivatives for the preparation of phosphonate NMDA antagonists | MERRELL PHARMACEUTICALS INC. (US) | 1996-09-10 | — | — | US | disclosed |
| EP-0613459-B1 | N-TRITYL ASPARTIC ACID DERIVATIVES FOR PREPARING PHOSPHONATE NMDA ANTAGONISTS | MERRELL DOW PHARMA (US) | 1996-03-06 | — | — | EP | disclosed |
| EP-0613459-B1 | N-TRITYL ASPARTIC ACID DERIVATIVES FOR PREPARING PHOSPHONATE NMDA ANTAGONISTS | MERRELL DOW PHARMA (US) | 1996-03-06 | — | — | EP | disclosed |
| EP-0613459-A1 | N-TRITYL ASPARTIC ACID DERIVATIVES FOR PREPARING PHOSPHONATE NMDA ANTAGONISTS. | MERRELL DOW PHARMA (US) | 1994-09-07 | — | — | EP | disclosed |
| EP-0613459-A1 | N-TRITYL ASPARTIC ACID DERIVATIVES FOR PREPARING PHOSPHONATE NMDA ANTAGONISTS. | MERRELL DOW PHARMA (US) | 1994-09-07 | — | — | EP | disclosed |
| WO-1993010075-A1 | N-TRITYL ASPARTIC ACID DERIVATIVES FOR PREPARING PHOSPHONATE NMDA ANTAGONISTS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1993-05-27 | — | — | WO | disclosed |
| WO-1993010075-A1 | N-TRITYL ASPARTIC ACID DERIVATIVES FOR PREPARING PHOSPHONATE NMDA ANTAGONISTS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1993-05-27 | — | — | WO | disclosed |